Literature DB >> 31893597

Enzymatic Biotransformation of Ginsenoside Rb2 into Rd by Recombinant α-L-Arabinopyranosidase from Blastococcus saxobsidens.

Ju-Hyeon Kim1,2, Jung-Mi Oh3, Sungkun Chun3, Hye Yoon Park4, Wan-Taek Im1,2,5.   

Abstract

In this study, we used a novel α-L-arabinopyranosidase (AbpBs) obtained from ginsenoside-converting Blastococcus saxobsidens that was cloned and expressed in Escherichia coli BL21 (DE3), and then applied it in the biotransformation of ginsenoside Rb2 into Rd. The gene, termed AbpBs, consisting of 2,406 nucleotides (801 amino acid residues), and with a predicted translated protein molecular mass of 86.4 kDa, was cloned into a pGEX4T-1 vector. A BLAST search using the AbpBs amino acid sequence revealed significant homology with a family 2 glycoside hydrolase (GH2). The over-expressed recombinant AbpBs in Escherichia coli BL21 (DE3) catalyzed the hydrolysis of the arabinopyranose moiety attached to the C-20 position of ginsenoside Rb2 under optimal conditions (pH 7.0 and 40°;C). Kinetic parameters for α-Larabinopyranosidase showed apparent Km and Vmax values of 0.078 ± 0.0002 micrometer and 1.4 ± 0.1 μmol/min/mg of protein against p-nitrophenyl-α-L-arabinopyranoside. Using a purified AbpBs (1 μg/ml), 0.1% of ginsenoside Rb2 was completely converted to ginsenoside Rd within 1 h. The recombinant AbpBs could be useful for high-yield, rapid, and low-cost preparation of ginsenoside Rd from Rb2.

Entities:  

Keywords:  Blastococcus saxobsidens; Ginsenoside Rb₂; biotransformation; ginsenoside Rd; α-L-arabinopyranosidase

Mesh:

Substances:

Year:  2020        PMID: 31893597     DOI: 10.4014/jmb.1910.10065

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  4 in total

Review 1.  Insights into Recent Studies on Biotransformation and Pharmacological Activities of Ginsenoside Rd.

Authors:  Xiaoping Song; Lina Wang; Daidi Fan
Journal:  Biomolecules       Date:  2022-03-28

Review 2.  Biotransformation, Pharmacokinetics, and Pharmacological Activities of Ginsenoside Rd Against Multiple Diseases.

Authors:  Jing Li; Qingxia Huang; Yao Yao; Peng Ji; E Mingyao; Jinjin Chen; Zepeng Zhang; Hongyu Qi; Jiaqi Liu; Zhaoqiang Chen; Daqing Zhao; Lei Zhou; Xiangyan Li
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

Review 3.  A review for discovering bioactive minor saponins and biotransformative metabolites in Panax quinquefolius L.

Authors:  Zhiyou Yang; Jiahang Deng; Mingxin Liu; Chuantong He; Xinyue Feng; Shucheng Liu; Shuai Wei
Journal:  Front Pharmacol       Date:  2022-08-01       Impact factor: 5.988

Review 4.  Diversity of Ginsenoside Profiles Produced by Various Processing Technologies.

Authors:  Xiang Min Piao; Yue Huo; Jong Pyo Kang; Ramya Mathiyalagan; Hao Zhang; Dong Uk Yang; Mia Kim; Deok Chun Yang; Se Chan Kang; Ying Ping Wang
Journal:  Molecules       Date:  2020-09-24       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.